ImmunologybioRxivPreprint
The CD19-4-1BBL antibody fusion protein unleashes the immune system against high-risk chronic lymphocytic leukemia
Priyanka Khare, Ronghua Zhang, Cristina Ivan…·Maria Teresa Sabrina Bertilaccio
This paper investigates the antileukemic effects of CD19-4-1BBL in chronic lymphocytic leukemia, showing it mitigates immunosuppression and enhances CD8+ T-cell immunity in preclinical models.
DOI 10.64898/2026.07.09.737515